Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe website revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA sitewide NIH notice was added announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology and linking to updates and FAQs.SummaryDifference0.7%

- Check28 days agoChange DetectedThe site footer now identifies the software revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedThe label for the 'Find contact information' link was standardized in the UI (capitalization change). The record history section now shows Revision: v3.7.0 instead of v3.6.6, reflecting a site update.SummaryDifference0.2%

- Check77 days agoChange DetectedA new revision v3.6.6 has been added to the study record history, replacing the previous v3.6.5. This reflects an update to the record metadata rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.